Trial intelligence / Profile preview

Intrauterine G-CSF for unresponsive thin endometrium before blastocyst transfer

ACTRN12611000907943Phase 3Recruiting

Sponsor
Fertility Specialists of Western Australia
Start
Jul 2012
Modality
Recombinant Proteins and Enzymes
Countries
1
01

Overview

Phase 3, open-label, single-arm trial of granulocyte colony-stimulating factor in Endometrial hypotrophy and Refractory endometrium, sponsored by Fertility Specialists of Western Australia. Primary endpoints: Improvement in endometrial thickness and Live birth rate. Started Jul 2012; status: recruiting.

02

Drugs

granulocyte colony-stimulating factor
03

Conditions

Endometrial hypotrophyRefractory endometrium

Beyond the preview

Go deeper on ACTRN12611000907943.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ACTRN12611000907943.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call